Predicting Abnormal Amyloid Burden: Can Machine Learning Become a Future Tool in Preventive Neurology?

Abstract

Authors

• Arman Eshaghi
  Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK. a.eshaghi@ucl.ac.uk.
• Rachel F Buckley
  Department of Neurology, Massachusetts General Hospital & Brigham and Women's, Harvard Medical School, Boston, MA, USA. rfbuckley@mgh.harvard.edu.

Keywords

External Resources